ID

25202

Descripción

Medication form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Palabras clave

  1. 28/8/17 28/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

28 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Medication Biologicals HepA/HepB vaccine 208127/125

Medication Biologicals HepA/HepB vaccine 208127/125

Header
Descripción

Header

Alias
UMLS CUI-1
C1320722
Protocol
Descripción

Protocol

Tipo de datos

text

Alias
UMLS CUI [1]
C1507394
Subject number
Descripción

Subject number

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Medication
Descripción

Medication

Alias
UMLS CUI-1
C0013227
Trade name
Descripción

Trade name

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Total Daily Dose
Descripción

Total daily dose

Tipo de datos

text

Alias
UMLS CUI [1]
C2348070
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Medical indication
Descripción

Where appropriate, medical indication should be recorded using the same terminology in the Adverse Experience Section.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
Code
Descripción

Please indicate the corresponding "code" of tbe reported. adverse experience if applicable (eg. "VO", "AE.2"), or code as "P" if used prophylactically in anticipation of vaccine reactions.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
Start Date
Descripción

day/month/year

Tipo de datos

date

Alias
UMLS CUI [1]
C0808070
End date, or tick box if continuing at end of study
Descripción

day/month/year

Tipo de datos

date

Alias
UMLS CUI [1]
C0806020
tick box if continuing at end of study
Descripción

Continuing at end of study

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1553904
UMLS CUI [1,2]
C2983670

Similar models

Medication Biologicals HepA/HepB vaccine 208127/125

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Header
C1320722 (UMLS CUI-1)
Protocol
Item
Protocol
text
C1507394 (UMLS CUI [1])
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
Medication
C0013227 (UMLS CUI-1)
Trade name
Item
Trade name
text
C2360065 (UMLS CUI [1])
Total daily dose
Item
Total Daily Dose
text
C2348070 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Medical indication
Item
Medical indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Code for medical indication
Item
Code
text
C0805701 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Start date
Item
Start Date
date
C0808070 (UMLS CUI [1])
End date
Item
End date, or tick box if continuing at end of study
date
C0806020 (UMLS CUI [1])
Continuing at end of study
Item
tick box if continuing at end of study
boolean
C1553904 (UMLS CUI [1,1])
C2983670 (UMLS CUI [1,2])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial